NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous with pink ribbons and messages of early detection, a global movement is preparing to shift the spotlight toward a more somber and urgent reality. On October 13, 2026, National Metastatic Breast Cancer Awareness Day, more than 325 landmarks across 20 countries will be bathed in teal, green, and pink. This coordinated display, known as the #LightUpMBC campaign, is spearheaded by METAvivor Research and Support, a non-profit organization dedicated to the only stage of breast cancer that remains incurable: Stage 4.
While Breast Cancer Awareness Month often focuses on "winning the battle" and the importance of mammograms, the #LightUpMBC initiative aims to highlight the 30% of breast cancer patients whose disease will metastasize, regardless of early detection or initial treatment success. The campaign serves as both a memorial for those lost and a beacon of hope for those currently living with the disease, aiming to turn symbolic illumination into tangible research funding.
Main Facts: A Global Beacon for the "Forgotten" Stage
The #LightUpMBC campaign is a massive logistical undertaking involving 195 cities and all 50 U.S. states. The choice of colors is deeply symbolic: teal represents healing and community, green symbolizes hope and renewal, and pink represents the breast cancer origins of the disease. Together, these colors form the official ribbon of metastatic breast cancer (MBC).
The centerpiece of the day’s activities is #LightUpMBC Live, a free global broadcast scheduled for 8 p.m. ET / 5 p.m. PT. Hosted by Tami Eagle Bowling, a veteran advocate living with MBC for 11 years, and Broadway star Kara Lindsay, the event merges scientific discourse with artistic performance. The broadcast will feature patient stories told from the sites of illuminated landmarks, insights from leading oncologists, and performances by high-profile artists, including Tony Award winner Victoria Clark and Tony nominee Dorian Harewood.
The primary objective of the campaign is to address a critical funding gap. Despite the high mortality rate associated with MBC, it historically receives only a small fraction of overall breast cancer research funding. METAvivor stands unique in the advocacy landscape because 100% of its net proceeds are funneled directly into Stage 4 research grants. The organization’s mission is to transition MBC from a terminal diagnosis into a manageable, chronic condition that allows for a high quality of life.
Chronology: From a Single Bridge to a Global Phenomenon
The origins of #LightUpMBC are rooted in a personal promise and a singular act of friendship. In 2017, the movement began with a single landmark: the Memorial Bridge in Portsmouth, New Hampshire. It was illuminated at the request of Laura Inahara in honor of her best friend, Jessica Moore.
Jessica Moore was diagnosed with metastatic breast cancer at the age of 32 and passed away just four years later. Her wish was simple: to see one local landmark light up in the MBC awareness colors to help people understand that "awareness" without research is insufficient for those at Stage 4.
Following Jessica’s death, Inahara founded the #LightUpMBC campaign. What began as a local tribute quickly resonated with the MBC community, which often feels alienated by the "pink-washing" of October. By 2020, the campaign had expanded to dozens of landmarks. By 2024, it had crossed international borders, illuminating sites in Europe and Asia.
In the lead-up to the 2026 event, the campaign has reached a historic milestone, having raised over $2.7 million for critical research since its inception. The 2026 iteration marks the largest participation to date, with iconic structures such as One World Trade Center in New York, the Willis Tower in Chicago, and the Mactan-Cebu Airport in the Philippines joining the roster. This growth reflects an increasing global recognition of the specific needs of the metastatic community.
Supporting Data: The Stark Reality of MBC in 2026
The necessity for the #LightUpMBC campaign is underscored by sobering statistics provided by the National Cancer Institute and the American Cancer Society. In 2026, an estimated 42,670 people in the United States are expected to die from breast cancer. This averages out to approximately 117 deaths every single day. Virtually all of these deaths are the result of metastatic disease.
Metastatic breast cancer occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to other parts of the body. The most frequent sites of metastasis are the bones, liver, lungs, and brain. Crucially, MBC is not a new type of cancer; if breast cancer spreads to the lungs, it is still treated as breast cancer, not lung cancer.
The data also challenges common misconceptions regarding "cures":
- Late-Stage Diagnosis: While some patients are diagnosed with Stage 4 "de novo" (from the start), many others develop metastatic disease years or even decades after being told they were "cancer-free" following treatment for early-stage disease.
- Treatment Longevity: For the MBC patient, treatment never ends. Even when scans show "No Evidence of Disease" (NED), the cancer is considered dormant or managed, not cured.
- Resistance: The greatest hurdle in MBC treatment is the cancer’s ability to mutate and become resistant to therapies. This necessitates a constant cycle of "treatment hopping," where patients move from one drug to the next as each one fails.
Research funded by METAvivor specifically targets these mechanisms of resistance and the biological drivers of metastasis, which differ significantly from the drivers of primary tumor growth.
Official Responses: Voices from the Front Lines
The leadership of METAvivor and the architects of #LightUpMBC emphasize that the campaign is about more than just aesthetics; it is about visibility for a marginalized population.
Dr. Kelly Shanahan, a physician and the Board President of METAvivor, provides a unique perspective as both a medical professional and a patient. "When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days because it is the only way we change the statistics. #LightUpMBC is the biggest contributor to this research and a vital way to bring our community together."
Laura Inahara, the campaign’s founder, reflected on the legacy of the woman who inspired the movement. "Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love. It teaches patients how to advocate for themselves and has raised millions for research that actually saves lives."
Tami Eagle Bowling, the campaign director and host of the live stream, highlighted the importance of the broadcast in connecting a physically dispersed community. "We are bringing the stories of patients directly from these landmarks into people’s homes. It’s about showing the world that we are here, we are living with this disease, and we are demanding a future where Stage 4 is not a death sentence."
Implications: Shifting the Narrative and Future Outlook
The #LightUpMBC campaign has significant implications for the future of cancer advocacy and public health policy. By reclaiming October 13 as a day specifically for Stage 4, the movement is successfully shifting the narrative of Breast Cancer Awareness Month from one of "prevention only" to one of "comprehensive care and research."
1. Empowerment through Advocacy:
The campaign encourages patients to move from passive recipients of care to active advocates. By using social media hashtags like #LightUpMBC and #METAvivor, patients and their families create a digital footprint that pressures pharmaceutical companies and governmental bodies to prioritize metastatic research.
2. The Push for Precision Medicine:
The funds raised through this campaign are increasingly directed toward precision medicine—treatments tailored to the genetic profile of an individual’s specific tumor. As research progresses, the goal is to develop a "chronic disease model" for MBC, similar to how HIV/AIDS was transformed from a terminal illness in the 1980s to a manageable condition today.
3. Psychological Impact:
For many patients, the "pink" messaging of October can be isolating, as it often celebrates survivors who have finished treatment. Seeing world-famous landmarks light up in teal and green provides a profound sense of validation and community for those who will be in treatment for the rest of their lives.
4. Economic Contributions to Science:
With over $2.7 million raised and 100% of net proceeds going to grants, METAvivor is filling a void left by larger organizations that may allocate significant portions of their budgets to overhead or general awareness. The 2026 campaign is expected to set a new record for single-day fundraising, potentially funding several multi-year research projects.
As October 13 approaches, the global community is invited to look toward the skyline. When the One World Trade Center or the Niagara Falls glow in teal, green, and pink, it will be more than a display of light; it will be a testament to the resilience of the metastatic community and a collective demand for a world where breast cancer no longer takes lives.
For those wishing to participate, METAvivor encourages the public to photograph local landmarks, share them on social media, and tune into the live stream at www.lightupmbc.org to support the ongoing quest for a cure.
About the Author
